TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.40$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Alx Oncology Holdings  (ALXO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -84 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ALXO
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-13 -14 -38 -68 -89 -130 -122 -84
0.4 0.4 0.2 0.1 0.3 0.8 0.9 0.7
0.3 0.3 5.4 14 24 26 27 13
0.3 0.3 6.6 19 24 – – –
-0.2 4.3 0.2 -4.0 9.9 8.3 -12 0.3
0.7 0.4 0.0 4.9 1.4 1.3 0.4 0.2
-0.7 -0.4 0.6 -4.9 -235 45 86 83
– – 0.0 2.8 – 60 – –
0.0 0.0 0.0 0.2 0.3 0.5 0.4 0.0
5.9 5.9 -6.5 -0.3 9.3 -0.4 -0.8 -1.4
0.0 15 463 2.5 9.9 59 31 0.4
-14 0.8 425 -71 -315 -26 -4.8 -1.2
-14 -15 -38 -73 -91 -132 -122 -84

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?